GAO: Rise in Drug Shortages Harming Patients

A pharmacist pours Truvada pills back into the bottle at Jack's Pharmacy on November 23, 2010 in San Anselmo, California.
National Journal
Clara Ritger
Add to Briefcase
See more stories about...
Clara Ritger
Feb. 10, 2014, 1:52 p.m.

The num­ber of drug short­ages has quad­rupled in the past five years, for­cing doc­tors and phar­macists to delay or ra­tion care, as life-sav­ing med­ic­a­tions re­main in short sup­ply, ac­cord­ing to the Gov­ern­ment Ac­count­ab­il­ity Of­fice on Monday.

There were 456 drug short­ages in 2012, and the trend was con­tinu­ing, with an­oth­er 361 drug short­ages re­por­ted by the middle of 2013, ac­cord­ing to the GAO re­port.

Drug-qual­ity is­sues and man­u­fac­tur­ing delays or shut­downs re­lated to qual­ity ac­coun­ted for 70 per­cent of drug short­ages re­por­ted between Jan. 1, 2011, and June 30, 2013, ac­cord­ing to the re­port.

The scarcity of cer­tain drugs in the mar­ket has jeop­ard­ized the abil­ity of care pro­viders to sta­bil­ize trauma vic­tims, con­trol pain dur­ing sur­gery, and treat heart dis­ease, said Mar­cia Crosse, GAO’s dir­ect­or of health care, at a con­gres­sion­al hear­ing on the re­port.

“The large num­ber of short­ages re­por­ted to the FDA sug­gests the mar­ket is still at risk of sup­ply dis­rup­tions,” Crosse said.

The Food and Drug Ad­min­is­tra­tion is re­spons­ible for over­see­ing drug qual­ity-prob­lems and work­ing with man­u­fac­tur­ers to rem­edy short­ages. Con­gress gran­ted the FDA great­er over­sight powers in 2012 after it passed the Food and Drug Ad­min­is­tra­tion Safety and In­nov­a­tion Act, re­quir­ing man­u­fac­tur­ers to no­ti­fy the agency of short­ages and re­quir­ing the agency to main­tain short­age data­bases and cre­ate ac­tion plans to solve them.

GAO cred­ited the FDA with mak­ing pro­gress in its goal to in­crease the avail­ab­il­ity of drugs, par­tic­u­larly gen­er­ics, in the face of short­ages. The FDA’s ef­forts to get drugs back on the mar­ket in­clude reg­u­lat­ory flex­ib­il­ity and ex­ped­ited re­views of new drugs.

While the num­ber of over­all drug short­ages re­mains high, the num­ber of new drug short­ages is fall­ing. There were 195 new short­ages in 2012, down from 255 in 2011.

“Our next task is to un­der­stand those longer-dur­a­tion short­ages,” said Douglas Throck­mor­ton, deputy dir­ect­or of reg­u­lat­ory pro­grams at the FDA.

Roughly 64 per­cent of new drug short­ages — 722 of the 1,132 re­por­ted to the FDA between Janu­ary 2007 and June 2013 — las­ted less than one year. But 14 per­cent las­ted more than two years, and some as long as four or more.

GAO re­com­mends that the FDA im­prove its data­base of drug short­ages and use the in­form­a­tion to ana­lyze trends and identi­fy risk factors to pre­vent fu­ture de­fi­cien­cies.

What We're Following See More »
PLAN C?
Senate Looks to Pass “Skinny Repeal” Then Negotiate with House
2 hours ago
THE LATEST

"Senate GOP leaders picked up support Wednesday for their plan to pass a scaled-back bill to repeal a handful of elements in the current health law, and then open negotiations with House Republicans to try to bring together their two very different bills."

Source:
“CLEAN REPEAL”
Senate Votes Down Repeal without Replace
8 hours ago
THE LATEST
SECOND QUARTER OF SALARY
Trump to Donate $100,000 to Dept. of Education
8 hours ago
THE LATEST
TURNED OVER NOTES
Manafort Testifies in Closed Session
1 days ago
THE LATEST

"Paul Manafort, who served as a top aide to President Trump’s 2016 campaign, on Tuesday provided congressional investigators notes he took during a Trump Tower meeting with a Russian lawyer that has emerged as a focus in the investigation of Russian interference in the election. Manafort’s submission, which came as he was interviewed in a closed session by staff members for the Senate Intelligence Committee, could offer a key contemporaneous account of the June 2016 session."

Source:
PENCE BREAKS THE TIE
Senate Will Debate House Bill
1 days ago
THE LATEST

By the narrowest of margins, the Senate voted 51-50 this afternoon to begin debate on the House's legislation to repeal and replace Obamacare. Sens. Lisa Murkowski and Susan Collins defected from the GOP, but Vice President Pence broke a tie. Sen. John McCain returned from brain surgery to cast his vote.

Source:
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login